SM
S. Mujwar
Chitkara University, Maharishi Markandeshwar University, Mullana, Maulana Azad National Institute of Technology, B. R. Nahata College of Pharmacy, GLA University, Barkatullah Vishwavidyalaya
0000-0003-4037-5475
Employment
-
Chitkara University Associate Professor2022 - Present
-
Maharishi Markandeshwar University, Mullana Associate Professor2021 - 2022
-
GLA University Assistant Professor2017 - 2021
Education
-
Maulana Azad National Institute of Technology Ph.D.2013 - 2018
-
B. R. Nahata College of Pharmacy M. Pharma.2009 - 2011
-
Barkatullah Vishwavidyalaya Bachelor of Pharmacy2005 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (88)
- Virtual Screening of Bacteriocins From Lactic Acid Bacteria Against Monkeypox DNA Polymerase: Sakacin P and Mundticin KS Emerge as Promising Candidates Save
- Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer Save
- Crystal structure, cytotoxicity, chemical reactivity, drug-likeness, and in silico studies of anthothecol from Khaya grandifoliola Save
- Crystal structure, cytotoxicity, chemical reactivity, drug-likeness, and in silico studies of anthothecol from Khaya grandifoliola Save
- Crystal structure, cytotoxicity, chemical reactivity, drug-likeness, and in silico studies of anthothecol from Khaya grandifoliola Save
- Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature Save
- Quinoline Heterocyclic Clubbed Hydrazone Derivatives as Potential Inhibitors of Mutant S. aureus DNA Gyrase A; An In Silico Drug Discovery Approach -Molecular Docking, MD Simulation, DFT Analysis and ADMET Predictions Save
- Structure-based design of plant-based dual inhibitors targeting AURKA1 and HDAC2 as potential anticancer agents Save
- Computational Drug Repurposing to Develop Human EAAT2 Receptor Agonists as Newer Therapeutics for Alzheimer’s Disease Save
- Pharmacological evaluation of Lonafarnib in reversing neurobehavioral, neurochemical and metabolic deficit in mouse models of chronic unpredictable mild stress (CUMS) Save